We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




In 3D Breast Screening, Two Views Are Best

By HospiMedica International staff writers
Posted on 15 May 2013
One-view, three-dimensional (3D) breast screening known as tomosynthesis, results in less radiation dose and approximately five seconds less compression; however, new findings revealed that obtaining both views is necessary to help ensure that a tumor will not be overlooked. More...


There are practices in Europe that have reported performing only a single view, specifically the mediolateral oblique (MLO) view, said Dr. Noa Beck, from Yale University (New Haven, CT, USA), and the lead author of the study. Two views are standard in the US for 3D breast screening,“ we wanted to see if one view would be sufficient,” she said.

Seven breast imagers reviewed 164 tumors visualized with tomosynthesis and noted on what views the cancers could be seen. The study found discovered that 56% of tumors were equally well seen on both the MLO view and the craniocaudal (CC) view; 34% of the cancers were either better or seen only on the CC view, according to Dr. Beck. “The CC view achieves better compression, and this likely explains the reason the CC view showed lesions more clearly. In a few cases, lesions were only seen on the MLO view because of where the cancers were located in the breast,” she said.

The results stressed that “obtaining both views is necessary to ensure that a cancer will be optimally visualized,” concluded Dr. Beck.

Dr. Beck presented her study’s findings at the American Roentgen Ray Society (ARRS) annual meeting on April 19, 2013, in Washington DC (USA).

Related Links:

Yale University





Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Radiofrequency Generator
GX1
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.